Skip to content

Effect of Exercise Training in Alzheimer's Patients

Effect of Exercise Training on Biochemical and Gait/Balance Parameters in Alzheimer's Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03981159
Acronym
ExCiTE-A
Enrollment
20
Registered
2019-06-10
Start date
2017-03-01
Completion date
2017-11-15
Last updated
2019-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease

Brief summary

The objective of this study was to examine the effects of exercise training on physical function and biochemical markers in elderly Alzheimer's disease patients.

Detailed description

Alzheimer's disease is a neurodegenerative disease characterized by progressive and irreversible degeneration of nerve cells. The loss of these cells leads to the continuous decline in muscle function with alterations in biochemical and haematological parameters. The objective of this study was to examine the effects of exercise training on physical function and biochemical markers in elderly Alzheimer's disease patients.

Interventions

OTHERPhysical training

Physical training for three months, twice per week (60 minutes per session).

Sponsors

University of Genova
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Non-pharmacological interventional study

Eligibility

Sex/Gender
ALL
Age
80 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Subjects with official diagnosis of Alzheimer's disease; * Subjects with MMSE higher than12.

Exclusion criteria

• Subjects with MMSE below 12 (indicating severe dementia and impairment).

Design outcomes

Primary

MeasureTime frameDescription
Tinetti testApproximately 10-15 minutesThe 3-likert test assesses balance and gait abilities with an individual sitting in an armless chair, rising up, staying standing, turning 360° and then sitting back down. Gait is scored over 12 and balance is scored over 16, totalling 28 points.
Berg Balance ScaleApproximately 20 minutesThe 14-item 5-likert (from 0 to 4) scale objectively determines a patient's balance ability during a series of predetermined tasks. Scores of each item are summed up: the total score ranges from 0 to 56. The lowest the score the lowest is the level of function, the highest the score the highest is the level of function.
6-minute walking test6 minutesThis test is a sub-maximal exercise used to evaluate aerobic capacity and endurance.
Timed up and go testApproximately 14 secondsThe test measures abilities of a patient initially in a seated position The patient is then asked to stand up up, walk 3 meters, turn around, walk back to the chair and sit down.
Walking While Talking testApproximately 1 minuteThis test is a dual-task test, consisting in walking while reciting the alphabet or alternate letters of the alphabet.
Red blood cell countApproximately 10-15 minutesAssessed with routine blood/biochemical assays
White blood cell countApproximately 10-15 minutesAssessed with routine blood/biochemical assays
HemoglobinApproximately 10-15 minutesAssessed with routine blood/biochemical assays
Platelet countApproximately 10-15 minutesAssessed with routine blood/biochemical assays
HematocritApproximately 10-15 minutesAssessed with routine blood/biochemical assays
TriglyceridesApproximately 10-15 minutesAssessed with routine blood/biochemical assays
CholesterolApproximately 10-15 minutesAssessed with routine blood/biochemical assays
Total bilirubinApproximately 10-15 minutesAssessed with routine blood/biochemical assays
AST (aspartate aminotransferase)Approximately 10-15 minutesAssessed with routine blood/biochemical assays
ALT (alanine aminotransferase)Approximately 10-15 minutesAssessed with routine blood/biochemical assays
Blood pressureApproximately 10-15 minutesAssessed with routine blood/biochemical assays
CreatinineApproximately 10-15 minutesAssessed with routine blood/biochemical assays
UreaApproximately 10-15 minutesAssessed with routine blood/biochemical assays
GlucoseApproximately 10-15 minutesAssessed with routine blood/biochemical assays
SodiumApproximately 10-15 minutesAssessed with routine blood/biochemical assays
CalciumApproximately 10-15 minutesAssessed with routine blood/biochemical assays
PotassiumApproximately 10-15 minutesAssessed with routine blood/biochemical assays

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026